source
- Valneva to cut up to 15% of workforce as travel slowdown lowers vaccine demandValneva, a French vaccine developer, announced it will lay off between 10% and 15% of its employees. The cuts are linked to a decline in demand for travel vaccines, which the company says is drive…
- Experts discuss combination and sequencing approaches for radiopharmaceuticals in advanced prostate cancerDr. Pedro Barata and Dr. Johann De Bono review the current questions surrounding how best to combine and sequence radiopharmaceutical therapies for patients with metastatic castration‑resistant pro…